Clinical Trial Update: Interferon Lambda for Immediate Antiviral Therapy at Diagnosis in COVID-19 [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating interferon lambda as immediate antiviral therapy at diagnosis for COVID-19 has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sars-cov-2

Snippet

Sponsor: University Health Network, Toronto | Conditions: Sars-CoV2, Covid-19 | Phase 2 | Status: COMPLETED